Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes.
about
Endocrine and other physiologic modulators of perinatal cardiomyocyte endowmentEarly origins of heart disease: low birth weight and determinants of cardiomyocyte endowmentUnexpected maturation of PI3K and MAPK-ERK signaling in fetal ovine cardiomyocytesRegulation of the cardiomyocyte population in the developing heart.Interactive roles of NPR1 gene-dosage and salt diets on cardiac angiotensin II, aldosterone and pro-inflammatory cytokines levels in mutant mice.Impact of maternal obesity on fetal programming of cardiovascular diseaseThyroid hormone drives fetal cardiomyocyte maturation.Mid-gestation ovine cardiomyocytes are vulnerable to mitotic suppression by thyroid hormone.Thyroid hormone is required for growth adaptation to pressure load in the ovine fetal heartHypoxia inhibits cardiomyocyte proliferation in fetal rat hearts via upregulating TIMP-4Differential activation of natriuretic peptide receptors modulates cardiomyocyte proliferation during developmentBinucleation of cardiomyocytes: the transition from a proliferative to a terminally differentiated state.The programming of cardiovascular disease.Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.Suppression of atrial natriuretic peptide/natriuretic peptide receptor-A-mediated signaling upregulates angiotensin-II-induced collagen synthesis in adult cardiac fibroblasts.Cardiomyokines from the heart.Systemic, but not cardiomyocyte-specific, deletion of the natriuretic peptide receptor guanylyl cyclase A increases cardiomyocyte number in neonatal mice.
P2860
Q26782516-C26BDCE2-EF5B-47C6-B853-4797BBBB5299Q28254243-9DF37DCA-EC99-458D-9AAA-1382ACFDBB8BQ34356150-B159363C-797E-40FB-961C-CA7F80B2EA75Q35032442-FC885C66-46AD-4ADD-89CF-BD5ACA049FFAQ35034572-86D1D992-15C5-481B-9452-B703A9858EAFQ35578658-FB2A7762-EA96-4479-BCB6-E286D4CA2879Q35648029-842AC99C-EBFD-434E-9C61-E738DD923326Q36225991-2AF58035-4343-4F8A-AEE6-582E3D60E50DQ36626105-B59EF9AF-8D66-4505-BD12-4AEB0376D4D1Q36770762-0F43FF53-70C0-4A5D-90B1-0624E068A4A2Q37429352-749FE64E-6329-4F76-8622-3EF4828CC555Q38159149-0F8BBC7B-6265-473B-826C-FD563173CC1CQ38546947-09BF7894-BB38-44AF-866C-425C86D14A73Q41511312-7D0596D1-A87E-416C-9B48-2E9A96EB39BDQ46322063-18B20031-14D1-422B-A7D9-6F7643CB9860Q47916949-C9F54574-6C87-46C0-AD20-E6CFB2DC2C1CQ51623809-B49810C3-766E-4024-8A5F-84F2A167D6D2
P2860
Atrial natriuretic peptide inhibits angiotensin II-stimulated proliferation in fetal cardiomyocytes.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@en
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@nl
type
label
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@en
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@nl
prefLabel
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@en
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@nl
P2093
P2860
P1476
Atrial natriuretic peptide inh ...... ation in fetal cardiomyocytes.
@en
P2093
G D Giraud
K L Thornburg
N N Chattergoon
P F O'Tierney
P2860
P304
P356
10.1113/JPHYSIOL.2010.191098
P407
P577
2010-06-02T00:00:00Z